Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
August 29, 2012
MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog
Cheng-Xiong Xu, Meng Xu, Lei Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers
Andrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
Martin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Plos One
|
December 1, 2023
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
Sharon E Robertson, Maya Yasukawa, Douglas C Marchion, et al.
Gynecologic Oncology
|
July 24, 2013
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest
Entidhar Al Sawah, Xin Chen, Douglas C Marchion, et al.
Plos One
|
November 23, 2021
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes
Daryoush Saeed-Vafa, Douglas C Marchion, Susan M McCarthy, et al.
Journal of Gynecologic Oncology
|
February 23, 2012
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
Nisha Bansal, Douglas C Marchion, Elona Bicaku, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 19, 2013
Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen
Gustavo C Rodriguez, H John Barnes, Kenneth E Anderson, et al.
Gynecologic Oncology
|
October 29, 2011
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
Hye Sook Chon, Douglas C Marchion, Yin Xiong, et al.
Oncology Reports
|
November 14, 2013
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
Ning Chen, Hye Sook Chon, Yin Xiong, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
August 29, 2012
MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog
Cheng-Xiong Xu, Meng Xu, Lei Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 18, 2005
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers
Andrew Berchuck, Edwin S Iversen, Johnathan M Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 9, 2019
Prediction of Distant Recurrence Using EndoPredict Among Women with ER<sup>+</sup>, HER2<sup>-</sup> Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only
Martin Filipits, Peter Dubsky, Margaretha Rudas, et al.
Plos One
|
December 1, 2023
Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
Sharon E Robertson, Maya Yasukawa, Douglas C Marchion, et al.
Gynecologic Oncology
|
July 24, 2013
Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest
Entidhar Al Sawah, Xin Chen, Douglas C Marchion, et al.
Plos One
|
November 23, 2021
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes
Daryoush Saeed-Vafa, Douglas C Marchion, Susan M McCarthy, et al.
Journal of Gynecologic Oncology
|
February 23, 2012
BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin
Nisha Bansal, Douglas C Marchion, Elona Bicaku, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 19, 2013
Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen
Gustavo C Rodriguez, H John Barnes, Kenneth E Anderson, et al.
Gynecologic Oncology
|
October 29, 2011
The BCL2 antagonist of cell death pathway influences endometrial cancer cell sensitivity to cisplatin
Hye Sook Chon, Douglas C Marchion, Yin Xiong, et al.
Oncology Reports
|
November 14, 2013
Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel
Ning Chen, Hye Sook Chon, Yin Xiong, et al.
Page
of 8